Promentis Pharmaceuticals
Pharmaceuticals, 826 N Plankinton Ave, Milwaukee, Wisconsin, 53203, United States, 1-10 Employees
Phone Number: 41********
Who is PROMENTIS PHARMACEUTICALS
Seeking To Redefine What Is Possible Promentis Pharmaceuticals, Inc., is a privately held biopharmaceutical company focused on the discovery and development of first-in-class therapies to...
Read More
-
Headquarters: 826 N Plankinton Ave, Milwaukee, Wisconsin, 53203, United States
-
Date Founded: 2007
-
Employees: 1-10
-
Revenue: Under $1 Million
-
Active Tech Stack: See technologies
Industry: Pharmaceuticals
SIC Code: 8731
Does something look wrong? Fix it. | View contact records from PROMENTIS PHARMACEUTICALS
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Promentis Pharmaceuticals
Answer: Promentis Pharmaceuticals's headquarters are located at 826 N Plankinton Ave, Milwaukee, Wisconsin, 53203, United States
Answer: Promentis Pharmaceuticals's phone number is 41********
Answer: Promentis Pharmaceuticals's official website is https://promentispharma.com
Answer: Promentis Pharmaceuticals's revenue is Under $1 Million
Answer: Promentis Pharmaceuticals's SIC: 8731
Answer: Promentis Pharmaceuticals has 1-10 employees
Answer: Promentis Pharmaceuticals is in Pharmaceuticals
Answer: Promentis Pharmaceuticals contact info: Phone number: 41******** Website: https://promentispharma.com
Answer: Seeking To Redefine What Is Possible Promentis Pharmaceuticals, Inc., is a privately held biopharmaceutical company focused on the discovery and development of first-in-class therapies to treat central nervous system (CNS) disorders. Promentis drug development program is focused on activating a unique target known to restore glutamatergic neurotransmission and imbalances in oxidative stress, key contributors to impaired cortical function linked to multiple CNS disorders. The Companys lead compound, SXC-2023, is being developed to treat various psychiatric disorders, with an initial focus on an indication that, despite representing a common disorder affecting millions of patients, has no FDA-approved treatment and a high level of patient need.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month